Core Scientific (CORZ) to Release Earnings on Wednesday

Core Scientific (NASDAQ:CORZ - Get Free Report) will likely be announcing its Q1 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $92.04 million for the quarter.

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.10) by $0.09. The company had revenue of $94.93 million for the quarter, compared to the consensus estimate of $97.07 million.

Core Scientific Stock Down 6.8 %

Shares of CORZ opened at $7.73 on Wednesday. The stock has a market cap of $2.28 billion, a PE ratio of -1.43 and a beta of 6.80. The business has a 50-day simple moving average of $8.15 and a two-hundred day simple moving average of $12.31. Core Scientific has a 12-month low of $2.88 and a 12-month high of $18.63.

Insider Buying and Selling at Core Scientific

In related news, Director Jordan Levy bought 62,500 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was bought at an average cost of $8.01 per share, for a total transaction of $500,625.00. Following the acquisition, the director now directly owns 306,887 shares of the company's stock, valued at $2,458,164.87. The trade was a 25.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Todd A. Becker sold 134,250 shares of Core Scientific stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the completion of the transaction, the director now directly owns 195,687 shares in the company, valued at approximately $2,103,635.25. The trade was a 40.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently issued reports on CORZ. Cantor Fitzgerald lowered their target price on Core Scientific from $24.00 to $21.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Keefe, Bruyette & Woods began coverage on shares of Core Scientific in a research note on Monday, January 27th. They set an "outperform" rating and a $22.00 price target for the company. HC Wainwright reissued a "buy" rating and issued a $17.00 price objective on shares of Core Scientific in a research note on Tuesday, March 11th. Craig Hallum began coverage on Core Scientific in a research report on Tuesday, January 21st. They set a "buy" rating and a $24.00 target price on the stock. Finally, Canaccord Genuity Group reaffirmed a "buy" rating and issued a $17.00 price objective on shares of Core Scientific in a research report on Wednesday, March 12th. Fifteen research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average price target of $19.07.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.